CMS Francis Lefebvre Advises ANJAC Group on Acquisition of HCG Group

"CMS Francis Lefebvre advised French cosmetics and nutraceutical manufacturer ANJAC on its acquisition of Slovenian nutraceutical group HCG, which comprises PharmaLinea, Hermes Consilium and Ergo Pharma. The deal expands ANJAC’s patent portfolio and R&D presence in Slovenia and includes a >€25m investment to triple Velenje production capacity by end-2026."

CMS Francis Lefebvre advised the ANJAC Group in its acquisition of the HCG Group, while a Slovenian counsel team assisted the HCG Group. The transaction brings the Ljubljana-based HCG Group into the ANJAC portfolio. Founded in 2017, HCG comprises three entities: PharmaLinea, a specialist in turnkey dietary supplement development; Hermes Consilium, a creator and distributor of high-end branded ingredients for nutritional products; and Ergo Pharma, a state-of-the-art production unit. Present in more than 40 international markets with approximately 130 employees, HCG reported average annual growth of 80% over the past three years. The acquisition is a strategic step for ANJAC to strengthen its global position in the nutraceuticals market. It broadens ANJAC’s portfolio of proprietary patents and clinical studies and adds two R&D sites in Slovenia. The plan also includes an investment programme exceeding €25 million to triple production capacity at the Velenje site by the end of 2026. CMS Francis Lefebvre represented client ANJAC with a team composed by: Marie-Charlotte Le Floch, counsel; Louise Paysant, avocat; Emma Cuvelier, avocat. Slovenian counsel represented client HCG with a team composed by: Saša Sodja; Martina Mahnič Smole; Gašper Hajdu.

CMS Francis Lefebvre Advises ANJAC Group on Acquisition of HCG Group

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads